Current position:Home >Product >
hydrogen [4-[4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, barium salt
hydrogen [4-[4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, barium salt(98493-34-6)
- Name: hydrogen [4-[4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, barium salt
- Synonyms:hydrogen [4-[4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, barium salt
- Molecular Formula:C54H50BaN8O16S4
- Molecular Weight:1332.6058
- CAS Registry Number:98493-34-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.98493-34-6 Hydrogen (4-(4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene)cyclohexa-2,5-dien-1-ylidene)dimethylammonium, barium salt
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 35104-88-2/STANNOUS PALMITATE
- 84929-49-7/Sarraceniapurpurea, ext.
- 5068-75-7/Ethanone,2-(2-imino-3-thiazolidinyl)-1-(3-nitrophenyl)-, hydrobromide (1:1)
- 5351-13-3/N-(4-fluorophenyl)-2,4,6-trimethylbenzenesulfonamide
- 71011-21-7/Fatty acids, tall-oil, polymers with benzoic acid, isononanoic acid, 9,11-linoleic acid, 10,12-linoleic acid, pentaerythritol and phthalic anhydride
- 93893-19-7/diammonium samarium pentanitrate
- 7228-51-5/azanide; 4-[[2-(4-cyanobenzoyl)-4-[2-(4-methyl-1-cyclohex-2-enyl)propan-2-yl]-1-cyclopenta-2,4-dienylidene]-hydroxy-methyl]benzonitrile; perchloric acid; silver
- 20507-22-6/tributyl(hydroxymethyl)phosphonium
- 37589-26-7/3-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-8-methyl-3,8-diazabicyclo[3.2.1]octane (2E)-but-2-enedioate
- 47956-45-6/dimethyloxosilane
- 72282-41-8/Osmium,nonacarbonyldi-m3-selenoxotri-, (2Os-Os) (9CI)
- 84083-10-3/trisodium 5-(acetylamino)-4-hydroxy-3-[[4-[[[2-methoxy-5-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]carbonyl]phenyl]azo]naphthalene-2,7-disulphonate
- 6502-05-2/ethyl (6-{[2-(2-carbamoylhydrazinylidene)propyl]amino}-4-[(diphenylmethyl)amino]-5-nitropyridin-2-yl)carbamate
- 6556-73-6/2,4,6-tri(cyclohex-3-en-1-yl)-1,3,5-trioxane
- 4038-56-6/2,6-diamino-5-octylpyrimidin-4(1H)-one
- 91673-31-3/Formaldehyde, reaction products with diethylamine and tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione
- 91080-00-1/Proteinhydrolyzates, pituitary gland
- 73559-41-8/Copper, [29H,31H-phthalocyaninetetrasulfonyl tetrachloridato-N29,N30,N31,N32]-, reaction products with N-cyclohexyl-1,3-propanediamine
- 54879-88-8/N-BENZYL-2,2-DIMETHOXYETHANAMINE
- 98493-34-6/hydrogen [4-[4-(dimethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, barium salt
- 68607-81-8/Silica gel, reaction products with chlorosulfuric acid and dichloromethyl(2-phenylpropyl)silane
- 16801-05-1/2-(2,4-dichlorophenyl)-6-hydroxy-4-oxo-4H-pyran-3-carboxylic acid
- 6746-13-0/1-(1,3-benzodioxol-5-ylmethyl)-4-[(2,5-dichlorophenyl)sulfonyl]piperazin-1-ium
- 57476-50-3/tert-Butyl 3-formyl-1h-indole-1-carboxylate
- 109522-29-4/5-fluoro-12-hydroxyeicosatetraenoic acid
- 400-91-9/3-BROMO-4,6-DINITROFLUOROBENZENE
- 94765-91-0/Nevastain B (9CI)
- 41945-43-1/naproxen glucuronide
- 6666-79-1/methyl (2E)-2-cyano-3-methylhex-2-enoate
- 94094-84-5/Amines,N-[3-[(3-aminopropyl)amino]propyl]-N(or N')-tallow alkyltrimethylenedi-, triacrylated